Developer docs
API playgroundTry for free, no card

Search company profiles

Biotechniques

Full company profile

uuid0036un3

Namestring
Biotechniques
Company typeenum
Private
Founded yearint
1983
Descriptiontext

BioTechniques is a specialist scientific publishing platform founded in 1983 and headquartered in London, United Kingdom, employing 51–100 people. The firm publishes original methods, tools, protocols, and techniques-oriented articles for the biotechnology research community, operating from the future-science.com domain under the Future Science Group umbrella. Its editorial scope includes coverage of emerging laboratory methods — for example, the journal featured connectomics (electron microscopy combined with AI for brain mapping), which Nature named Method of the Year for 2025, including a mouse visual cortex connectome of over 200,000 cells and 523 million synapses.

The associated Future Medicine platform extends the business beyond traditional journal publishing into a multi-format healthcare media ecosystem. It comprises four core content pillars: Future Medicine TV (a creator-led video platform with at least eight show series hosted by named academic and clinical figures covering AI in healthcare, neurotech, digital eye health, surgery, and mental health), Deep Dives (written articles), Events (conference coverage spanning Digital Health Rewired, Giant Health, The Surgeon Show, and others), and Profiles (company and innovator spotlights). Content is distributed globally via the futuremedicine.com website and active LinkedIn, YouTube, Instagram, and X channels.

The revenue model centers on a consumer subscription membership priced at £2.99 per month after a 30-day free trial, supplemented by likely advertising, event sponsorship, and any institutional journal licensing (not disclosed in the source data). No revenue figures, subscriber counts, funding history, or enterprise customer logos are disclosed, and ownership or parent-company structure is not characterized in the available sources beyond the future-science.com domain association.

Short descriptiontext

BioTechniques is a London-based scientific publisher (founded 1983, 51–100 employees) producing methods, protocols, and techniques content for biotech researchers, extended via the Future Medicine platform into video, articles, events coverage, and a £2.99/month consumer membership.

Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
scientific methods publishing, healthcare media platform, research protocol journal, life sciences editorial content, medical expert video content
Industry2 codes
PRIMARYEDAGAGAA
Medical & Clinical Reference (Physicians, Nursing, Allied Health)
Education/Educational Publishing & Learning Content/Professional & Technical Reference Publishing
SECONDARYEDAGANAJ
Healthcare & Clinical Professional Development (CME/CE)
Education/Educational Publishing & Learning Content/Professional Development & Training Materials
NAICS code1 code
  • Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers51621
Product category
Healthcare Media and Scientific Publishing
Social media profiles1 record
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Marketing or Sales, Technology or R&D
GTM typeB2B
B2B
Offering typeDigital Commerce or Conte…
Digital Commerce or Content
Core offering1 text field

BioTechniques operates a multi-platform healthcare content media brand (Future Medicine) that publishes creator-led video shows, in-depth written articles (Deep Dives), industry event coverage, and innovator/company profiles. The platform aggregates expert insights from named healthcare thought leaders and professors across topics including AI in healthcare, digital health, neurotechnology, robotics, surgery, and personalized medicine, with access gated behind a paid membership (£2.99/month after a 30-day free trial).

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • First complete connectomes of organisms including C. elegans, Drosophila, and mammalian brain sample
Product overview1 text field

Future Medicine is a multi-platform healthcare content media company offering a unified content ecosystem comprising Future Medicine TV (video shows), Deep Dives (articles), Events (conference coverage), and Profiles (company spotlights). The platform features multiple show series hosted by healthcare thought leaders covering topics including AI in healthcare, digital health, neurotechnology, robotics, surgery, and personalized medicine. Content is available via subscription membership at £2.99/month after a free trial.

Product and service5 records
1Future Medicine TV
CategoryVideo content platform
Description

A creator-led video platform where healthcare's leading minds share unfiltered insights under studio lights, covering AI, digital health, neurotech, surgery, and mental health. Targeted at healthcare professionals and industry stakeholders.

2Deep Dives
CategoryWritten editorial content
Description

Long-form written articles providing in-depth analysis of important developments in medicine, including opinion pieces, company spotlights, and technology reviews (e.g., HealthTech, NHS AI, robotics in surgery, BioTechX content). Targeted at healthcare professionals seeking analysis below the surface of medical developments.

3Events
CategoryEvent coverage content
Description

Event coverage section providing rich insights from top healthcare industry events including Digital Health Rewired, The Surgeon Show, Giant Health, and Answer Digital. Targeted at healthcare professionals who cannot attend events in person.

4Profiles
CategoryCompany and innovator spotlights
Description

Company and innovator profile spotlights showcasing technologies transforming healthcare, including features on VitVio (surgical workflow), Nucleome Therapeutics (drug discovery), Holly Health (personalized health coaching), and Deep Medical. Targeted at healthcare professionals and industry stakeholders tracking emerging innovators.

5Future Medicine Membership
CategorySubscription service
Description

Subscription membership providing access to Future Medicine's full content ecosystem (Future Medicine TV, Deep Dives, Events, Profiles). Priced at £2.99 per month after a 30-day free trial. Targeted at healthcare professionals and industry stakeholders.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Current Protocols
TypeDirect peer
Description

Wiley's long-running protocols reference library covering molecular biology, bioinformatics, immunology and related fields. Comparable to BioTechniques as a recurring-updated methods reference for bench scientists.

TypeBroad incumbent
Description

Largest U.S. professional network for physicians with a content/news layer. Comparable to Future Medicine as a subscription-supported platform monetizing HCP audience attention, though anchored on networking rather than editorial video.

TypeDirect peer
Description

Open-access peer-reviewed protocol repository for life-science researchers. Direct competitor to BioTechniques' core journal content on detailed step-by-step experimental procedures.

TypeEmerging player
Description

HIMSS Media publication covering health-IT, EHR, and digital transformation. Comparable to Future Medicine's AI/NHS/robotics coverage as B2B healthcare technology media targeting digital health decision makers.

TypeDirect peer
Description

Peer-reviewed video methods journal serving life-science researchers with visual protocols. Comparable to BioTechniques' journal plus the Future Medicine TV video layer combined.

TypeBroad incumbent
Description

Boston Globe Media's health and life-sciences news outlet serving HCPs, researchers, and industry. Comparable to Future Medicine as a subscription-supported healthcare content brand, though at significantly larger scale and broader editorial scope.

TypeEmerging player
Description

B2B news and events platform covering digital health, biotech, and health-tech innovation. Comparable to the Future Medicine Events and Profiles sections in audience (innovation-focused healthcare decision makers) and content format.

TypeDirect peer
Description

Step-by-step protocols journal from Springer Nature. Closely comparable to BioTechniques in both content type (detailed laboratory methods) and target reader (working life-science researchers).

TypeDirect peer
Description

Springer Nature's flagship methods journal publishing novel experimental techniques in the life sciences. Directly comparable to BioTechniques as a peer-reviewed methods/protocols publication serving the same bench-researcher audience.

10Methods (Elsevier journal)
TypeDirect peer
Description

Elsevier's methods-focused journal publishing original methodology across molecular biology, biochemistry, and analytical chemistry. Comparable niche positioning to BioTechniques.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Biotechniques

Healthcare Media and Scientific Publishingfuture-science.com

BioTechniques is a London-based scientific publisher (founded 1983, 51–100 employees) producing methods, protocols, and techniques content for biotech researchers, extended via the Future Medicine platform into video, articles, events coverage, and a £2.99/month consumer membership.

What Biotechniques does

BioTechniques is a specialist scientific publishing platform founded in 1983 and headquartered in London, United Kingdom, employing 51–100 people. The firm publishes original methods, tools, protocols, and techniques-oriented articles for the biotechnology research community, operating from the future-science.com domain under the Future Science Group umbrella. Its editorial scope includes coverage of emerging laboratory methods — for example, the journal featured connectomics (electron microscopy combined with AI for brain mapping), which Nature named Method of the Year for 2025, including a mouse visual cortex connectome of over 200,000 cells and 523 million synapses.

The associated Future Medicine platform extends the business beyond traditional journal publishing into a multi-format healthcare media ecosystem. It comprises four core content pillars: Future Medicine TV (a creator-led video platform with at least eight show series hosted by named academic and clinical figures covering AI in healthcare, neurotech, digital eye health, surgery, and mental health), Deep Dives (written articles), Events (conference coverage spanning Digital Health Rewired, Giant Health, The Surgeon Show, and others), and Profiles (company and innovator spotlights). Content is distributed globally via the futuremedicine.com website and active LinkedIn, YouTube, Instagram, and X channels.

The revenue model centers on a consumer subscription membership priced at £2.99 per month after a 30-day free trial, supplemented by likely advertising, event sponsorship, and any institutional journal licensing (not disclosed in the source data). No revenue figures, subscriber counts, funding history, or enterprise customer logos are disclosed, and ownership or parent-company structure is not characterized in the available sources beyond the future-science.com domain association.

Biotechniques firmographics

Firmographics
Name
Biotechniques
Website
https://future-science.com
Company type
Private
Founded year
1983
Headcount range
1–10 employees
Short description
BioTechniques is a London-based scientific publisher (founded 1983, 51–100 employees) producing methods, protocols, and techniques content for biotech researchers, extended via the Future Medicine platform into video, articles, events coverage, and a £2.99/month consumer membership.
Ownership category
akta.pro rank

Biotechniques industry classification

Industry
Product category
Healthcare Media and Scientific Publishing
NAICS
Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers (51621)
akta.pro industry
PRIMARYEDAGAGAA
Medical & Clinical Reference (Physicians, Nursing, Allied Health)
Education/Educational Publishing & Learning Content/Professional & Technical Reference Publishing
SECONDARYEDAGANAJ
Healthcare & Clinical Professional Development (CME/CE)
Education/Educational Publishing & Learning Content/Professional Development & Training Materials

Keywords

  • Scientific methods publishing
  • Healthcare media platform
  • Research protocol journal
  • Life sciences editorial content
  • Medical expert video content

Where Biotechniques is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

Biotechniques business model

Business model
GTM type
B2B
Offering type
Digital Commerce or Content
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D

Distribution channels1 record

Marketing channels4 records

Biotechniques product offering

Product offering

Core offering

BioTechniques operates a multi-platform healthcare content media brand (Future Medicine) that publishes creator-led video shows, in-depth written articles (Deep Dives), industry event coverage, and innovator/company profiles. The platform aggregates expert insights from named healthcare thought leaders and professors across topics including AI in healthcare, digital health, neurotechnology, robotics, surgery, and personalized medicine, with access gated behind a paid membership (£2.99/month after a 30-day free trial).

Product overview

Future Medicine is a multi-platform healthcare content media company offering a unified content ecosystem comprising Future Medicine TV (video shows), Deep Dives (articles), Events (conference coverage), and Profiles (company spotlights). The platform features multiple show series hosted by healthcare thought leaders covering topics including AI in healthcare, digital health, neurotechnology, robotics, surgery, and personalized medicine. Content is available via subscription membership at £2.99/month after a free trial.

Differentiator

Problem solved

Functional benefit

Products and services

  • Future Medicine TV A creator-led video platform where healthcare's leading minds share unfiltered insights under studio lights, covering AI, digital health, neurotech, surgery, and mental health. Targeted at healthcare professionals and industry stakeholders.
  • Deep Dives Long-form written articles providing in-depth analysis of important developments in medicine, including opinion pieces, company spotlights, and technology reviews (e.g., HealthTech, NHS AI, robotics in surgery, BioTechX content). Targeted at healthcare professionals seeking analysis below the surface of medical developments.
  • Events Event coverage section providing rich insights from top healthcare industry events including Digital Health Rewired, The Surgeon Show, Giant Health, and Answer Digital. Targeted at healthcare professionals who cannot attend events in person.
  • Profiles Company and innovator profile spotlights showcasing technologies transforming healthcare, including features on VitVio (surgical workflow), Nucleome Therapeutics (drug discovery), Holly Health (personalized health coaching), and Deep Medical. Targeted at healthcare professionals and industry stakeholders tracking emerging innovators.
  • Future Medicine Membership Subscription membership providing access to Future Medicine's full content ecosystem (Future Medicine TV, Deep Dives, Events, Profiles). Priced at £2.99 per month after a 30-day free trial. Targeted at healthcare professionals and industry stakeholders.

Quantifiable outcome

  • First complete connectomes of organisms including C. elegans, Drosophila, and mammalian brain sample

Companies that use Biotechniques

Customer profile

Ideal customer profiles1 record

Biotechniques technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature1 record

Biotechniques partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Biotechniques competitors and assessment

Company assessment

Direct peers

  • Current Protocols: Wiley's long-running protocols reference library covering molecular biology, bioinformatics, immunology and related fields. Comparable to BioTechniques as a recurring-updated methods reference for bench scientists.
  • Bio-protocol: Open-access peer-reviewed protocol repository for life-science researchers. Direct competitor to BioTechniques' core journal content on detailed step-by-step experimental procedures.
  • JoVE: Peer-reviewed video methods journal serving life-science researchers with visual protocols. Comparable to BioTechniques' journal plus the Future Medicine TV video layer combined.
  • Nature Protocols: Step-by-step protocols journal from Springer Nature. Closely comparable to BioTechniques in both content type (detailed laboratory methods) and target reader (working life-science researchers).
  • Nature Methods: Springer Nature's flagship methods journal publishing novel experimental techniques in the life sciences. Directly comparable to BioTechniques as a peer-reviewed methods/protocols publication serving the same bench-researcher audience.
  • Methods (Elsevier journal): Elsevier's methods-focused journal publishing original methodology across molecular biology, biochemistry, and analytical chemistry. Comparable niche positioning to BioTechniques.

Broad incumbents

  • Doximity: Largest U.S. professional network for physicians with a content/news layer. Comparable to Future Medicine as a subscription-supported platform monetizing HCP audience attention, though anchored on networking rather than editorial video.
  • STAT News: Boston Globe Media's health and life-sciences news outlet serving HCPs, researchers, and industry. Comparable to Future Medicine as a subscription-supported healthcare content brand, though at significantly larger scale and broader editorial scope.

Emerging players

  • Healthcare IT News: HIMSS Media publication covering health-IT, EHR, and digital transformation. Comparable to Future Medicine's AI/NHS/robotics coverage as B2B healthcare technology media targeting digital health decision makers.
  • MedCity News: B2B news and events platform covering digital health, biotech, and health-tech innovation. Comparable to the Future Medicine Events and Profiles sections in audience (innovation-focused healthcare decision makers) and content format.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Biotechniques social profiles

Digital presence

Biotechniques financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Biotechniques leadership team

Management profile

Number of profiles

Biotechniques funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Biotechniques M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotechniques

What does Biotechniques do?

BioTechniques operates a multi-platform healthcare content media brand (Future Medicine) that publishes creator-led video shows, in-depth written articles (Deep Dives), industry event coverage, and innovator/company profiles. The platform aggregates expert insights from named healthcare thought leaders and professors across topics including AI in healthcare, digital health, neurotechnology, robotics, surgery, and personalized medicine, with access gated behind a paid membership (£2.99/month after a 30-day free trial).

When was Biotechniques founded?

Biotechniques was founded in 1983. It employs 1 to 10 people.

Where is Biotechniques based?

Biotechniques is headquartered in London, United Kingdom, in the Europe region.

Who are Biotechniques's main competitors?

Direct peers on record are Current Protocols, Bio-protocol, JoVE, Nature Protocols, Nature Methods and Methods (Elsevier journal). Broad incumbents are Doximity and STAT News. Emerging players are Healthcare IT News and MedCity News.

Does Biotechniques have an API?

No public API is recorded for Biotechniques.

What industry is Biotechniques in?

Biotechniques's product category is Healthcare Media and Scientific Publishing. Its primary akta.pro industry code is EDAGAGAA, Medical & Clinical Reference (Physicians, Nursing, Allied Health), with a secondary code of EDAGANAJ, Healthcare & Clinical Professional Development (CME/CE). Its NAICS code is 51621.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals